Immunology and Microbiology
Adaptive Immune System
13%
Agonist
9%
Astrocyte
7%
Blood Brain Barrier
12%
Blood Plasma
10%
Bone Marrow-Derived Macrophage
6%
Brain Tissue
7%
CCR5
6%
CD34
12%
CD4
8%
Central Nervous System
9%
Cerebrospinal Fluid
5%
Dendritic Cell
8%
Glycoprotein
5%
Hematopoietic Stem Cell
23%
Human Cell
13%
Human Immunodeficiency Virus
59%
Human Immunodeficiency Virus 1
100%
Human Immunodeficiency Virus Infection
15%
Humanized Mouse
76%
Immunopathology
5%
Infectious Agent
7%
Interleukin 34
9%
Leukocyte
6%
Lymphocyte
5%
Macrophage
35%
Microglia
15%
Monocyte
12%
Mouse
53%
Mouse Model
15%
NSG Mouse
9%
Secretion (Process)
6%
Single Photon Emission Computed Tomography
6%
Sonic Hedgehog
9%
T-Helper Cell
6%
Viral Disease
13%
Viral Load
6%
Viral Replication
5%
Virus Type
19%
Pharmacology, Toxicology and Pharmaceutical Science
Antivirus Agent
13%
Atazanavir
19%
Atazanavir Plus Ritonavir
7%
Biodistribution
5%
Blood-Brain Barrier
11%
Cabotegravir
5%
Disease
20%
Disorders of Higher Cerebral Function
17%
Dolutegravir
7%
Efavirenz
11%
Folate Receptor
9%
Folic Acid
10%
HIV
64%
HIV Associated Dementia
7%
Human Immunodeficiency Virus 1
25%
Human Immunodeficiency Virus 1 Infection
8%
Human Immunodeficiency Virus Infection
10%
Infection
23%
Mixed Lineage Kinase 3
7%
Mouse
55%
Nanogel
9%
Nanoparticle
13%
Neuroprotective Agent
5%
Pharmacodynamics
15%
Rilpivirine
5%
Ritonavir
16%
RNA Directed DNA Polymerase Inhibitor
9%
SCID Mouse
5%
Subcutaneous Injection
5%
Viral Clearance
5%
Keyphrases
Adoptive Transfer
7%
Antiretroviral
8%
Antiretroviral Activity
5%
Antiretroviral Therapy
9%
Atazanavir
7%
Bone Marrow
5%
CD34+ Stem Cells
6%
Copolymer-1
11%
Efavirenz
7%
Encephalitis
14%
Human Immunodeficiency Virus Type 1 (HIV-1)
51%
Humanized Mice
24%
IL-34
9%
Immune Response
7%
Liver
5%
Macrophages
5%
Monocyte-derived Macrophages
6%
Mouse Model
5%
Neuroprotective Activity
5%
NOG Mice
8%
URMC-099
5%
Virus
6%